Abstract
In this chapter we shall consider: how drugs get into the body; their fate within the body; how they are eliminated; their time course within the body (their pharmacokinetics); and also the general mechanisms by which they produce a response (their pharmacodynamics). In addition we shall cover some of the reported differences between adults and children with regard to the fate and effects of drugs in the body. To date these have been confined mainly to pharmacokinetic differences. This topic is naturally one of the more technical and does require some knowledge of high school biology and chemistry. We shall cover the general principles, but also some of the more technical aspects (mostly for prescribing physicians) will be addressed. These may be skipped by those seeking only some basic understanding of how drugs work.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Pond SM, Tozer TN: First-pass elimination. Basic concepts and clinical consequences. Clin Pharmacokinet 9: 1–25, 1984.
Merkle HP: Transdermal delivery systems. Meth Find Exp Clin Pharmacol 11: 135–153, 1989.
Bates IP: Permeability of the blood brain barrier. Trends Pharm Sci 4: 447–450, 1985.
Huang J, Oie S: Effect of intra-individual change in serum protein binding on the pharmacological response of R-and S-disopyramide in the rabbit. Res Commun Chem Pathol Pharmacol 41: 243–253, 1983.
Rowland M: Plasma protein binding and therapeutic drug monitoring. Ther Drug Monitor 2: 29–37, 1980.
Paxton JW: Alpha1-acid glycoprotein and binding of basic drugs. Meth Find Exp Clin Pharmacol 5: 635–648, 1983.
Rollins DE: Pharmacokinetics and drug excretion in bile, in Benet LZ, Massoud N, Gambertoglio JG (eds): Pharmacokinetic Basis for Drug Treatment. New York, Raven Press, 1985, p 77.
Sjöqvist F, Bertilsson L: Clinical pharmacology of antidepressant drugs: Pharmacogenetics, in Usdin E, et al (eds): Frontiers in Biochemical and Pharmacological Research in Depression. New York, Raven Press, 1984, p 359.
Vesell ES: Pharmacogenetics. Introduction: Genetic and environmental factors affecting drug response in man. Fed Proc 31: 1253–1258, 1972.
Clark DWJ: Genetically determined variability in acetylation and oxidation status; clinical implications. Drugs 29: 342–345, 1985.
Montamat SC, Cusack BJ, Vestal RE: Management of drug therapy in the elderly. N Engl J Med 321: 303–309, 1989.
Lane EA, Guthrie S, Linnoila M: Effects of ethanol on drug and metabolite pharmacokinetics. Clin Pharmacokinet 10: 228–247, 1985.
Sitar DS: Human drug metabolism in vivo. Pharmacol Ther 433: 363–375, 1989.
Barry M, Feely J: Enzyme induction and inhibition. Pharmacol Ther 48: 71–94, 1990.
Richens A, Dunlop A: Serum phenytoin levels in the management of epilepsy. Lancet 2: 247–248, 1975.
Garattini S: Active drug metabolites. An overview of their relevance in clinical pharmacokinetics. Clin Pharmcokinet 10: 216–227, 1985.
Kearns GL, Reed MD: Clinical pharmacokinetics in infants and children: A reappraisal. Clin Pharmacokinet 17 (suppl 1): 29–67, 1989.
Morselli PL: Clinical pharmacology of the perinatal period at early infancy. Clin Pharmacokinet 17 (suppl 1): 13–28, 1989.
Friis-Hansen B: Body composition during growth: In vivo measurements and biochemical data correlated to differential anatomical growth. Pediatrics 47 (suppl): 264–274, 1971.
Friis-Hansen B: Water distribution in the foetus and new-born infant. Acta Paediatr Scand 305 (suppl): 7–11, 1983.
Burchell B, Coughtrie M, Jackson M, et al: Development of human liver UDP-glucuronosyl-transferase. Dev Pharmacol Ther 13: 70–77, 1989.
Boreus LO: Pharmacokinetics in children, in Boreus LO (ed): Principles of Pediatric Pharmacology. London, Churchill Livingstone, 1982, p 135.
Gilman JT: Therapeutic drug monitoring in the neonate and paediatric age group: Problems and clinical pharmacokinetic implications. Clin Pharmacokinet 19: 1–10, 1990.
Lamble JW, Abbott AC (eds): Receptors, Again. Amsterdam, Elsevier Science Publishers, 1984.
Yamamura HI, Enna SJ, Kuhar MJ: Neurotransmitter Receptor Binding. New York, Raven Press, 1987.
Alberts B, Bray D, Lewis J, et al: Molecular Biology of the Cell, ed. 2. New York, Garland, 1989.
Schofield PR, Shivers BD, Seeburg PH: The role of receptor subtype diversity in the CNS. Trends Neurosci 13: 1990.
Neubig RR, Thomsen WJ: How does a key fit a flexible lock? Structure and dynamics in receptor function. BioEssays 11: 136–141, 1989.
Webster RA, Jordan CC (eds): Neurotransmitters, Drugs and Disease. Oxford, Blackwell Scientific Publications, 1989.
Birdsall NJM: Receptor structure: The accelerating impact of molecular biology. Trends Pharm Sci 10: 50–52, 1989.
Watson SP, James W: PCR and the cloning of receptor subtype genes. Trends Pharm Sci 10: 346–347, 1989.
Turner AJ, Bachelard HS (eds): Neurochemistry—A Practical Approach. Oxford, IRL Press, 1987.
Neer EJ, Clapham DE: Roles of G protein subunits in transmembrane signalling. Nature 333: 129–134.
Dragunow M, Currie RW, Faull RLM, et al: Immediate-early genes, kindling and long-term potentiation. Neurosci Biobehav Rev 13: 301–313, 1989.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Paxton, J.W., Dragunow, M. (1993). Pharmacology. In: Werry, J.S., Aman, M.G. (eds) Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2884-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2884-5_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44389-3
Online ISBN: 978-1-4615-2884-5
eBook Packages: Springer Book Archive